Paris, France

Antonio Ugolini

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Massy, FR (2011)
  • Paris, FR (2010 - 2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Antonio Ugolini: Innovator in Pharmaceutical Chemistry

Introduction

Antonio Ugolini is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of MET inhibitors. With a total of 5 patents to his name, Ugolini's work has the potential to impact medical treatments significantly.

Latest Patents

Ugolini's latest patents include innovative compounds such as 6-triazolopyridazine sulfanyl benzothiazole derivatives. These compounds are designed as MET inhibitors, which are crucial in the treatment of various medical conditions. The disclosures related to these patents detail the compounds' formulas and their pharmaceutical compositions, emphasizing their potential use as medicaments.

Career Highlights

Throughout his career, Ugolini has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Ugolini has collaborated with several professionals in his field, including Eric Bacque and Eva Albert. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Antonio Ugolini stands out as a significant figure in pharmaceutical innovation, with a focus on developing effective MET inhibitors. His contributions through patents and collaborations continue to shape the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…